DETAILED ACTION
Notice of Pre-AIA or AIA Status
The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA .
Following office action has been formulated as second Non-Final rejection since new double patenting rejection has been added over the copending application number 18/989,540 and 18/989,656, see analysis below.
Claim Status
Applicant’s amendment of claims 1, 5, 9, 13, 15 submitted on 08/11/2026 has been acknowledged. Applicant has added claim 21 a new claim. Claims 1-6 and 8-21 are pending and they are examined in this office action.
Rejections that are withdrawn
Objection to claims has been withdrawn in light of applicant’s amendment of claims use consistent terminology “accession number” in claims.
35 USC § 112 – Indefiniteness rejection is withdrawn in light of applicant’s amendment of claims to recite the deposit information (i.e. NCMA accession No.) and amendment of claim 9 to recite the haploid and double haploid techniques as breeding techniques.
35 USC § 112 – enablement rejection has been withdrawn in light of applicant’s amendment of claims and specification to include acceptable deposit.
Following analysis over 35 USC § 112 Written description requirements rejection has been modified in light of applicant’s amendment of claims 1, 5, 9, 13, 15, cancellation of claim 7 and addition of new claim 21.
Claim Rejections - 35 USC § 112 – Written description requirements
The following is a quotation of the first paragraph of 35 U.S.C. 112(a):
(a) IN GENERAL.—The specification shall contain a written description of the invention, and of the manner and process of making and using it, in such full, clear, concise, and exact terms as to enable any person skilled in the art to which it pertains, or with which it is most nearly connected, to make and use the same, and shall set forth the best mode contemplated by the inventor or joint inventor of carrying out the invention.
The following is a quotation of the first paragraph of pre-AIA 35 U.S.C. 112:
The specification shall contain a written description of the invention, and of the manner and process of making and using it, in such full, clear, concise, and exact terms as to enable any person skilled in the art to which it pertains, or with which it is most nearly connected, to make and use the same, and shall set forth the best mode contemplated by the inventor of carrying out his invention.
Claims 13-21 remain rejected under 35 U.S.C. 112(a) or 35 U.S.C. 112 (pre-AIA ), first paragraph, as failing to comply with the written description requirement. The claim(s) contains subject matter which was not described in the specification in such a way as to reasonably convey to one skilled in the relevant art that the inventor or a joint inventor, or for applications subject to pre-AIA 35 U.S.C. 112, the inventor(s), at the time the application was filed, had possession of the claimed invention.
Regarding claim 13-21, the claims are drawn to a wheat plant produced by introducing a locus conversion into wheat variety 6PVJT00B, wherein the locus conversion is introduced by backcrossing or genetic transformation.
There are no limitations on the number of crosses or steps to produce such plants. Second, there are no limitations on what characteristics the plant must have, such that one of skill in the art would be able to determine whether or not they were in possession of the claimed subject matter. The specification at pages 11-12 notes that a locus conversion “refers to plants within a variety that have been modified in a manner that retains the overall genetics of the variety and further comprises one or more loci with a specific desired trait”. However, while there is a lower limit, there appears to be no upper limit to how many loci may be altered such that literally all the traits of the plant listed in the specification could be altered and still be considered a locus conversion if those are the desired modified traits.
In contrast, the specification only describes wheat variety 6PVJT00B, and methods of using said variety. The specification does not describe any other varieties or locus conversions, nor does the specification indicate what traits and genetics must be kept in order to be considered a variety with a locus conversion as instantly claimed.
Accordingly, the claims as written lack an adequate written description over their entire breadth, and Applicant does not appear to have been in possession of the claimed genus of wheat plants at the time of filing.
Response to Arguments
Applicant's arguments filed 08/11/2026 have been fully considered but they are not persuasive.
Applicant argues they have amended claims 13 and 15 to recite that the plant, plant part, seed, or plant cell comprising the locus conversions otherwise (aside from the locus conversion) comprises all the physiological and morphological characteristics of wheat variety 6PVJT00B when grown under the same environmental conditions. Applicant argues wheat variety 6PVJT00B is described not only by the traits listed in Table 2, but also by the seed deposit which encompasses the genetics of wheat variety 6PVJT00B, therefore the description is adequate (Response to Rejection, page 7, first paragraph).
Applicant's arguments have been fully considered but they are not persuasive since there is no limit on the locus conversion, it is not clear which of the physiological and morphological traits are locus converted and which are retained. The genomic structure of the plant would have any changes in its structure since there is no lower limit on conservation of its endogenous locus to distinguish it from any other wheat plant. Therefore the rejection has been maintained. Applicant are advised to recite single locus conversion.
Double Patenting
The nonstatutory double patenting rejection is based on a judicially created doctrine grounded in public policy (a policy reflected in the statute) so as to prevent the unjustified or improper timewise extension of the “right to exclude” granted by a patent and to prevent possible harassment by multiple assignees. A nonstatutory double patenting rejection is appropriate where the conflicting claims are not identical, but at least one examined application claim is not patentably distinct from the reference claim(s) because the examined application claim is either anticipated by, or would have been obvious over, the reference claim(s). See, e.g., In re Berg, 140 F.3d 1428, 46 USPQ2d 1226 (Fed. Cir. 1998); In re Goodman, 11 F.3d 1046, 29 USPQ2d 2010 (Fed. Cir. 1993); In re Longi, 759 F.2d 887, 225 USPQ 645 (Fed. Cir. 1985); In re Van Ornum, 686 F.2d 937, 214 USPQ 761 (CCPA 1982); In re Vogel, 422 F.2d 438, 164 USPQ 619 (CCPA 1970); In re Thorington, 418 F.2d 528, 163 USPQ 644 (CCPA 1969).
A timely filed terminal disclaimer in compliance with 37 CFR 1.321(c) or 1.321(d) may be used to overcome an actual or provisional rejection based on nonstatutory double patenting provided the reference application or patent either is shown to be commonly owned with the examined application, or claims an invention made as a result of activities undertaken within the scope of a joint research agreement. See MPEP § 717.02 for applications subject to examination under the first inventor to file provisions of the AIA as explained in MPEP § 2159. See MPEP § 2146 et seq. for applications not subject to examination under the first inventor to file provisions of the AIA . A terminal disclaimer must be signed in compliance with 37 CFR 1.321(b).
The filing of a terminal disclaimer by itself is not a complete reply to a nonstatutory double patenting (NSDP) rejection. A complete reply requires that the terminal disclaimer be accompanied by a reply requesting reconsideration of the prior Office action. Even where the NSDP rejection is provisional the reply must be complete. See MPEP § 804, subsection I.B.1. For a reply to a non-final Office action, see 37 CFR 1.111(a). For a reply to final Office action, see 37 CFR 1.113(c). A request for reconsideration while not provided for in 37 CFR 1.113(c) may be filed after final for consideration. See MPEP §§ 706.07(e) and 714.13.
The USPTO Internet website contains terminal disclaimer forms which may be used. Please visit www.uspto.gov/patent/patents-forms. The actual filing date of the application in which the form is filed determines what form (e.g., PTO/SB/25, PTO/SB/26, PTO/AIA /25, or PTO/AIA /26) should be used. A web-based eTerminal Disclaimer may be filled out completely online using web-screens. An eTerminal Disclaimer that meets all requirements is auto-processed and approved immediately upon submission. For more information about eTerminal Disclaimers, refer to www.uspto.gov/patents/apply/applying-online/eterminal-disclaimer.
Claims 1-6 and 8-21 are provisionally rejected on the ground of nonstatutory double patenting as being unpatentable over claims 1-20 of copending Application No. 18/989,540 (reference application) (Also published as US Application Pub. No.: US 2026/0174039 A1, hereafter cited as ‘039) and further in view of Knott et al. (Published: 2008, Journal: Crop Sci. 48:1807–1816). Although the claims at issue are not identical, they are not patentably distinct from each other because.
Application ‘039 claims a plant, plant part, seed, or plant cell of wheat variety 6PNRC72B (claim 1). Like the instantly claimed wheat plant, 6PNRC72B was developed from same cross between three homozygous lines contributing by pedigree: 25% of variety 6PSQD81B, 25% of variety 6PKJH92B and 50% of variety 6PWGL11B, and bred and selected using the doubled haploid method (page 15, paragraph 0108-0110). Since the lines were developed by doubled haploid technique, the line would have near identical genomic structure and the seed would be representative seed of the instant variety 6PVJT00B. The descriptions of each plant show few differences between them; these include some differences in disease resistance scores (Table 2 in each application) and seed coat color. Bock et al. (Published: 2020, Journal: Phytopathology Research 2:9 https://doi.org/10.1186/s42483-020-00049-8) showed the evidence that disease rating variation would have been caused by variation in rater, rating environments etc. (page 5, left paragraphs 2-4 and right paragraphs 1-3). Therefore disease ratings would have been varied.
Furthermore, ‘039 has classified their wheat variety 6PNRC72B as soft white (SW) (see Table 2), wherein applicant has classified their wheat variety as soft red winter (SRW), see Table 2.
It was known in the art to convert a SW wheat into SRW wheat by selecting Red x White crosses. Knott et al. teaches seed coat color in common wheat is controlled by three homeologus loci located on the long arms of chromosomes 3A, 3B, and 3D wherein red seed coat color is dominant to white (page 1807, right first paragraph). Knott et al. teaches method of breeding soft white line from white x red crosses ( see Figure 1 and 2). Knott et al. teaches SW wheat line can be produced relatively easily within existing SRW wheat breeding program (page 1815, left paragraph 4).
Therefore, it would have been obvious that a skilled in the art would have selected applicant’s SW line as 6PVJT00B from the segregates from the SRW line of ‘039’s 6PNRC72B. with the SW line taught as taught by Knott et al. that would produce the applicant’s SW line as 6PVJT00B and someone would do that by a locus conversion of specific locus taught by Knott et al. for white coat color.
Furthermore, 6PVJT00B seed appears to be indistinguishable from a locus conversions and backcross progeny seed of the variety 6PNRC72B, and 6PVJT00B plants appear to be indistinguishable from plants produced by introducing a locus conversion into wheat variety 6PNRC72B.
Applicant’s claims 1-6 and 8-20 has same recitations of the plant and seed of the wheat plant, F1 hybrid produced and further modification of the wheat plant by a breeding method or locus conversions. Furthermore, claim 12 of ‘039’s recite the method of producing nucleic acid from the wheat plant, so someone skilled in the art would produce the nucleic acid from converted plant.
Claims 1-6 and 8-21 are provisionally rejected on the ground of nonstatutory double patenting as being unpatentable over claims 1-20 of copending Application No. 18/989,656 (reference application) (also published as US Application Pub. No.: US 20260174041 A1, hereafter cited as ‘041) and further in view of Knott et al. (Published: 2008, Journal: Crop Sci. 48:1807–1816). Although the claims at issue are not identical, they are not patentably distinct from each other because.
Application ‘041 claims a plant, plant part, seed, or plant cell of wheat variety 6PNRC72B (claim 1). Like the instantly claimed wheat plant, 6PNRC72B was developed from same cross between three homozygous lines contributing by pedigree: 25% of variety 6PSQD81B, 25% of variety 6PKJH92B and 50% of variety 6PWGL11B, and bred and selected using the doubled haploid method (page 15, paragraph 0108-0110). Since the lines were developed by doubled haploid technique, the line would have near identical genomic structure and the seed would be representative seed of the instant variety 6PVJT00B. The descriptions of each plant show few differences between them; these include some differences in disease resistance scores (Table 2 in each application) and seed coat color. Bock et al. (Published: 2020, Journal: Phytopathology Research 2:9 https://doi.org/10.1186/s42483-020-00049-8) showed the evidence that disease rating variation would have been caused by variation in rater, rating environments etc. (page 5, left paragraphs 2-4 and right paragraphs 1-3). Therefore disease ratings would have been varied.
Furthermore, ‘041 has classified their wheat variety 6PNRC72B as soft white (SW) (see Table 2), wherein applicant has classified their wheat variety as soft red winter (SRW), see Table 2.
It was known in the art to convert a SW wheat into SRW wheat by selecting Red x White crosses. Knott et al. teaches seed coat color in common wheat is controlled by three homeologus loci located on the long arms of chromosomes 3A, 3B, and 3D wherein red seed coat color is dominant to white (page 1807, right first paragraph). Knott et al. teaches method of breeding soft white line from white x red crosses ( see Figure 1 and 2). Knott et al. teaches SW wheat line can be produced relatively easily within existing SRW wheat breeding program (page 1815, left paragraph 4).
Therefore, it would have been obvious that a skilled in the art would have selected applicant’s SW line as 6PVJT00B from the segregates from the SRW line of ‘041’s 6PNRC72B. with the SW line taught as taught by Knott et al. that would produce the applicant’s SW line as 6PVJT00B and someone would do that by a locus conversion of specific locus taught by Knott et al. for white coat color.
Furthermore, 6PVJT00B seed appears to be indistinguishable from a locus conversions and backcross progeny seed of the variety 6PNRC72B, and 6PVJT00B plants appear to be indistinguishable from plants produced by introducing a locus conversion into wheat variety 6PNRC72B.
Applicant’s claims 1-6 and 8-20 has same recitations of the plant and seed of the wheat plant, F1 hybrid produced and further modification of the wheat plant by a breeding method or locus conversions. Furthermore, claim 12 of ‘041’s recite the method of producing nucleic acid from the wheat plant, so someone skilled in the art would produce the nucleic acid from converted plant.
This is a provisional nonstatutory double patenting rejection because the patentably indistinct claims have not in fact been patented.
Summary
No claim is allowed.
Close Prior Art
The closest prior art is Laskar et al. (US Pub. No.: US 2022/0061257 A1, Pub. Date: Mar.3, 2022) which teaches a Soft Red Winter (SRW) variety 6PJEF74B having most of the same characteristics of the instantly claimed Applicant’s variety (page 15, paragraph 0122, Table 2). However, the parental varieties used to arrive at wheat variety 6PJEF74B (page 14, paragraph 0119) differ from those used to arrive at the instantly claimed variety such that wheat variety 6PJEF74B does not have all the genetics of the instantly claimed variety.
Examiner’s Contact Information
Any inquiry concerning this communication or earlier communications from the examiner should be directed to SANTOSH SHARMA whose telephone number is (571)272-8440. The examiner can normally be reached Mon-Fri 8:00 AM - 5:00 PM.
Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice.
If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, AMJAD A. ABRAHAM can be reached at (571)270-7058. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300.
Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000.
/SANTOSH SHARMA/Examiner, Art Unit 1663
/Amjad Abraham/SPE, Art Unit 1663